Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-Term Outcomes of a Multicenter Aspirin Deprescribing Intervention.

JAMA network open·2026

Same author

Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study.

The American journal of medicine·2025

Same author

A Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism.

JACC. Advances·2025

Same author

Outcomes of direct oral anticoagulants with aspirin vs warfarin with aspirin: a registry-based cohort study.

Research and practice in thrombosis and haemostasis·2024

Same author

Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome.

The Journal of clinical investigation·2024

Same author

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Cancer-associated thrombosis.

¹Division of Hematology/Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. suman.sood@uphs.upenn.edu

Current Opinion in Hematology

|July 17, 2009

Summary

This summary is machine-generated.

Cancer patients face high risks of venous thromboembolic disease (VTE). Identifying high-risk individuals is key for effective VTE prevention and treatment, balancing efficacy with bleeding risks.

More Related Videos

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Published on: February 2, 2015

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Related Experiment Videos

Last Updated: Jun 21, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Three-dimensional Co-culture Model for Tumor-stromal Interaction

Published on: February 2, 2015

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

Area of Science:

Oncology
Hematology
Thrombosis Research

Background:

Venous thromboembolic disease (VTE) significantly contributes to morbidity and mortality in cancer patients.
Coagulation pathway activation is implicated in tumor progression and aggressive disease development.

Purpose of the Study:

To review novel risk factors and predictors for VTE in cancer patients.
To explore current and future approaches for VTE treatment and prevention in malignancies.

Main Methods:

Review of current literature on cancer-associated thrombosis.
Identification of individual comorbidities, cancer-specific factors, and therapies influencing VTE risk.
Evaluation of novel risk stratification tools, including biomarkers and predictive modeling.

Main Results:

Factors like comorbidities, cancer stage, and angiogenesis inhibitors increase VTE risk.
Biomarkers such as P-selectin and D-dimer aid in risk stratification.
Prophylaxis with anticoagulants is effective and well-tolerated in hospitalized patients, but its role in ambulatory patients requires further investigation.

Conclusions:

Routine VTE prophylaxis for all cancer patients is not recommended due to heterogeneous risk and bleeding concerns.
Identifying specific patient subgroups at high risk for VTE or bleeding is crucial for targeted prophylaxis.